Company intelligence / Profile preview

Oxford Technology & Innovations Fund

Oxford, England, United Kingdom

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Venture capital firm/fund specializing in early-stage investments for deep science, technology, and health innovations, often supporting companies spun out from UK universities, especially within 60 miles of Oxford. They do not themselves develop drugs/therapeutics—their “pipeline” is the set of investee companies, many of which are preclinical/clinical-stage in biotech, diagnostics, or healthtech.

Therapeutic areas: ImmunologyEndocrinologyGastroenterologyInfectious DiseasesMetabolic DisordersOtherOncology
Modalities: Small moleculeMonoclonal antibodyGene therapyOncolytic virus therapyVaccine
Industry: Investors

Beyond the preview

Go deeper on Oxford Technology & Innovations Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxford Technology & Innovations Fund.

Explore the full profile